Quick Summary
Covering the latest research from top Wall Street investment banks

Ferrari: Full-Year Earnings More Balanced, Order Book Strong with No Unusual Cancels

Institution
UBS
Date
2026-05-05
Authors
Zuzanna Pusz, Patrick Hummel
Company
Ferrari NV
Ticker
RACE.US
Industry
Auto Manufacturers
Rating
Buy
BullishHigh confidenceReiterateMedium-termMaintain Buy rating, $483 target price implying 42.5% upside
AuthorsZuzanna Pusz, Patrick Hummel
Target price$483
CoverageOther
Business segmentsCars and Spare Parts、Engines、Sponsorship, Commercial and Brand、Other
Research firm divisions/subsidiariesUBS Europe SE(Subsidiary/Legal Entity)

AI summary card

Ferrari: Full-Year Earnings More Balanced, Order Book Strong with No Unusual Cancels

Management confirmed that 2026 earnings will be more evenly distributed, with limited impact from Middle East conflict, order book extended to end of 2027, and no unusual cancellations observed.

Buy | Target Price $483
FerrariMeeting MinutesStrong OrdersEarnings BalanceMiddle East ImpactFX Risk
  • Full-year earnings distribution is expected to be more even, reducing the gap between H1 and H2 performance
  • Order book extends through end of 2027, with no signs of abnormal cancellations
  • The impact of Middle East conflicts on Q1 results was limited
  • No immediate supply chain cost pressures; prepared against potential tariffs
  • Annual FX negative impact estimated at ~€200 million

Report interpretation

Overview

UBS issued meeting minutes following a call with Ferrari's CEO and CFO. The company outperformed expectations in Q1 (OSG +6% vs consensus +4%), but management emphasized that full-year earnings will be more balanced rather than front-loaded. The order book has been extended to the end of 2027 without any abnormal cancellations; impacts from Middle East conflicts and potential U.S. tariff risks are considered manageable. An annual FX drag of approximately €200 million is anticipated. UBS maintains its Buy rating and $483 target price.

Core views

Demand: A strong and expanding order book reflects resilient demand. Management disclosed orders have been pushed out to the end of 2027 for some models which are already sold out, with others still growing and there were no observations of abnormally high cancellations. Supply & Earnings Timing: Earnings timing is becoming more balanced. After adjusting for country and product mix, the company expects a more uniform distribution of profits across both halves of 2026, moving away from the historical 'front-weighted' pattern. Cost & External Risks: Currently, there is no sign of inflationary pressure on costs. Ferrari reports no indication of increased supplier costs and has applied strategies learned from last year to hedge against potential tariffs; an annual FX negative impact of about €200 million is forecasted. New Product Timeline: Pre-orders for the Ferrari Luce model have not yet opened; they will commence after the complete vehicle launch this month.

Analysis framework

UBS assesses the manageability of full-year earnings pacing and external risks by directly engaging with management, considering order visibility, regional revenue structures, and cost pass-through mechanisms, maintaining its relative EV/EBITDA-based valuation approach.

Methodology notes

  • Valuation MethodEV/EBITDA valuation

    Relative EV/EBITDA Multiple Approach

    UBS compares Ferrari’s EV/EBITDA multiples to those of luxury sector peers like Hermès and LVMH, making adjustments for lease accounting effects to derive the target price.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

  • Ferrari NV (RACE.US)
    Focus of Meeting Minutes, Maintain Buy Recommendation
    Strengths
    Robust Order Book, Premium Branding, Improved Profit Timing
    Weaknesses
    FX Negative Impact ~€200M, Potential Tariff and Supply Chain Disruptions
    Comparison
    Valuation Compared to Luxury Sector Peers, EV/EBITDA Still Reasonable
    Risks
    Global High-End Consumption Slowdown, Declining Brand Strength, Insufficient Electrification Transition

Key data

  • 2026 FX Drag~€200 millionAnnual Forecast
  • Current Market Cap$60.4 billionAs of Report Publication Date
  • 2026e EV/EBITDA17.4xUBS Forecast
  • 2027e EV/EBITDA15.9xUBS Forecast
  • Target Price Implied Upside42.5%Based on Current Share Price

Impact & implications

UBS believes Ferrari has successfully smoothed its annual earnings profile by adjusting region and product mix, reducing exposure to single-quarter volatility risks; a long order book coupled with no abnormal cancellations demonstrates brand resilience; manageable costs and tariff risks, along with quantified FX impacts, support the continued attractiveness of the stock. Maintaining a Buy rating and $483 target price, corresponding to 17.4x 2026e EV/EBITDA, remains favorable given the context.

Risks

  • Risk of Global High-End Consumption Slowdown
  • Brand Power Risk Due to F1 Performance or Innovation Downturn
  • Electrification Transition and Regulatory Changes Risk
  • Material Price Volatility and Supply Chain Interruptions

What to watch

  • Order Opening Status for Ferrari Luce Model Post Full Launch
  • Actual Impact of FX and Tariffs in Second Half of Year
Zhejiang ICP No. 2022035445-5
Disclaimer: Market data, charts, indicators, research views, and other information provided on this website are intended solely for information display, research communication, and educational reference. They should not be regarded as personalized investment advice, securities recommendations, trading instructions, solicitations, or guarantees of return. While we strive to improve the reliability of our data and content, such information may still be subject to delays, errors, incompleteness, or untimely updates due to source differences, methodological limitations, system processing, or market volatility. Users should exercise independent judgment based on their own circumstances and bear all risks and responsibilities arising from the use of this website.

Settings

Sign in to view recent logins